ARCHIVES

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

This article is from The Cancer Letter archive.

Vol. 23 No. 32 | August 15, 1997

Download PDF Visit The Full Archive

Related Articles

In Brief: Monaco, Yarbro Named To Pharmacopeial Board; Gene Therapy Trial For ADA Clears First Hurdle

March 23, 1990

Letrozole Combination Increases PFS In ER+ and HER2-Negative Breast Cancer

January 25, 2013

NCCS Plans Rays Of Hope Event At Ellipse On Sept. 15.

July 27, 2001

Senate Bill Would Prohibit Political Appointments To Advisory Groups

January 9, 1976

Immunoassays For Isoenzymes

April 15, 1983

Cornel Student Withdraws In Wake Of Discrepancies Found In Study

September 18, 1981